Dashboard
Manage Tickers

MCMoelis & Co

NYSE moelis.com


$ 62.21 $ -2.03 (-3.16 %)    

Friday, 02-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 62.22
$ 61.97 x 103
-- x --
-- - --
$ 37.19 - $ 70.00
1,003,792
na
4.72B
$ 1.14
$ 353.62
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-24-2024 06-30-2024 10-Q
2 04-24-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 07-26-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 04-29-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 10-31-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-28-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 08-02-2017 06-30-2017 10-Q
30 05-04-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-03-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 03-14-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 08-06-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jp-morgan-maintains-neutral-on-moelis-raises-price-target-to-51
JP Morgan Maintains Neutral on Moelis, Rai...
07/25/2024 14:01:02

JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:MC) with a Neutral and raises the price target from $50 to $51.

keefe-bruyette--woods-reiterates-market-perform-on-moelis-raises-price-target-to-60
Keefe, Bruyette & Woods Reiterates Market ...
07/25/2024 13:18:14

Keefe, Bruyette & Woods analyst Aidan Hall reiterates Moelis (NYSE:MC) with a Market Perform and raises the price target...

moelis-q2-2024-adj-eps-018-beats-011-estimate-sales-264586m-beat-227373m-estimate
Moelis Q2 2024 Adj EPS $0.18 Beats $0.11 E...
07/24/2024 20:48:36

Moelis (NYSE:MC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.11 by 63.64 per...

evaluating-moelis-insights-from-5-financial-analysts
Evaluating Moelis: Insights From 5 Financi...
07/23/2024 18:01:46

morgan-stanley-maintains-underweight-on-moelis-raises-price-target-to-61
Morgan Stanley Maintains Underweight on Mo...
07/23/2024 17:34:52

Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:MC) with a Underweight and raises the price target from $51 to $61.

jp-morgan-maintains-neutral-on-moelis-lowers-price-target-to-50
JP Morgan Maintains Neutral on Moelis, Low...
07/11/2024 21:41:07

JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:MC) with a Neutral and lowers the price target from $54 to $50.

ubs-maintains-sell-on-moelis-raises-price-target-to-50
UBS Maintains Sell on Moelis, Raises Price...
07/09/2024 19:58:11

UBS analyst Brennan Hawken maintains Moelis (NYSE:MC) with a Sell and raises the price target from $47 to $50.

moelis-announces-resignation-of-jonathan-kaye-following-punching-incident
Moelis Announces Resignation Of Jonathan K...
06/24/2024 14:18:10

- Bloomberg

moelis-reportedly-reviewing-options-for-777-partners-football-assets
Moelis Reportedly Reviewing Options For 77...
05/23/2024 20:23:26

- Bloomberg

ubs-maintains-sell-on-moelis-raises-price-target-to-47
UBS Maintains Sell on Moelis, Raises Price...
04/25/2024 15:02:06

UBS analyst Brennan Hawken maintains Moelis (NYSE:MC) with a Sell and raises the price target from $45 to $47.

unveiling-5-analyst-insights-on-moelis
Unveiling 5 Analyst Insights On Moelis
04/25/2024 14:00:46

keefe-bruyette--woods-reiterates-market-perform-on-moelis-lowers-price-target-to-54
Keefe, Bruyette & Woods Reiterates Market ...
04/25/2024 13:32:19

Keefe, Bruyette & Woods analyst Aidan Hall reiterates Moelis (NYSE:MC) with a Market Perform and lowers the price target...

moelis-q1-2024-adj-eps-022-beats-013-estimate-sales-217485m-miss-219305m-estimate
Moelis Q1 2024 Adj EPS $0.22 Beats $0.13 E...
04/24/2024 20:30:01

Moelis (NYSE:MC) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.13 by 69.23 per...

4-analysts-have-this-to-say-about-moelis
4 Analysts Have This To Say About Moelis
04/09/2024 21:01:06

jmp-securities-reiterates-market-perform-on-moelis
JMP Securities Reiterates Market Perform o...
04/09/2024 17:22:08

JMP Securities analyst Devin Ryan reiterates Moelis (NYSE:MC) with a Market Perform.

ubs-maintains-sell-on-moelis-lowers-price-target-to-45
UBS Maintains Sell on Moelis, Lowers Price...
03/26/2024 10:12:16

UBS analyst Brennan Hawken maintains Moelis (NYSE:MC) with a Sell and lowers the price target from $46 to $45.

assessing-moelis-insights-from-4-financial-analysts
Assessing Moelis: Insights From 4 Financia...
03/13/2024 12:01:04

goldman-sachs-upgrades-moelis-to-neutral-raises-price-target-to-58
Goldman Sachs Upgrades Moelis to Neutral, ...
03/13/2024 08:54:35

Goldman Sachs analyst James Yaro upgrades Moelis (NYSE:MC) from Sell to Neutral and raises the price target from $53 to $58.

moelis-announces-continued-expansion-of-its-energy-franchise-appoints-stephen-trauber-as-chairman
Moelis Announces Continued Expansion Of It...
02/28/2024 14:14:52

Appoints Stephen Trauber as Chairman and Global Head of Energy and Clean TechnologyEnergy bankers Muhammad Laghari and Alexande...

xylem-dexcom-and-2-other-stocks-insiders-are-selling
Xylem, DexCom And 2 Other Stocks Insiders ...
02/22/2024 12:55:49

The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)